New South Korean biocluster vies for Asian investment
This article was originally published in Scrip
Executive Summary
South Korea has completed basic infrastructure work for a new life sciences cluster it is looking to position as a major regional centre and which will provide new competition for Singapore's Biopolis. Several national agencies, including the Korean FDA, are preparing to relocate to the site.